当前位置:首页 - 行情中心 - 威高骨科(688161) - 财务分析 - 利润表

威高骨科

(688161)

  

流通市值:106.56亿  总市值:106.56亿
流通股本:4.00亿   总股本:4.00亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入290,185,005.081,452,715,790.191,083,278,467.47750,539,867.68
营业收入290,185,005.081,452,715,790.191,083,278,467.47750,539,867.68
二、营业总成本235,809,633.561,193,304,728.68909,362,061.83650,646,993.9
营业成本105,406,408.4497,838,010.75382,759,040.67269,648,572.74
税金及附加4,202,950.3718,062,135.0612,457,012.388,247,860.39
销售费用83,171,306480,836,119.2371,892,305.06278,608,139.32
管理费用20,030,911.8492,378,796.4564,551,696.7740,288,736.85
研发费用28,643,022.81119,904,588.2591,157,022.5463,648,262.46
财务费用-5,644,965.86-15,714,921.03-13,455,015.59-9,794,577.86
其中:利息费用35,953.051,041,884.62223,771157,389.97
其中:利息收入5,932,529.5618,010,682.115,616,496.9210,868,762.35
加:公允价值变动收益221,249.32317,350.788,219.18-
加:投资收益7,580,071.6726,784,454.9319,653,093.0714,447,824.97
资产处置收益-6,373,713.49-124,113.08-124,113.08
资产减值损失(新)-57,089.14-39,993,874.05-12,488,219.36-12,234,957.87
信用减值损失(新)3,619,674.747,416,938.8910,335,866.433,476,608.28
其他收益3,371,676.5711,390,976.029,228,735.986,792,599.71
营业利润平衡项目0000
四、营业利润69,110,954.68271,700,621.49200,609,987.86112,250,835.79
加:营业外收入93,744.81255,326.49307,683.81267,904.21
减:营业外支出448,449.291,014,689.68860,676.51839,470.45
利润总额平衡项目0000
五、利润总额68,756,250.2270,941,258.3200,056,995.16111,679,269.55
减:所得税费用16,208,143.5242,656,131.7331,630,383.515,510,567.52
六、净利润52,548,106.68228,285,126.57168,426,611.6696,168,702.03
持续经营净利润52,548,106.68228,285,126.57168,426,611.6696,168,702.03
归属于母公司股东的净利润51,789,016.82223,751,739.09164,293,158.9993,129,877.9
少数股东损益759,089.864,533,387.484,133,452.673,038,824.13
(一)基本每股收益0.130.560.410.23
(二)稀释每股收益0.130.560.410.23
九、综合收益总额52,548,106.68228,285,126.57168,426,611.6696,168,702.03
归属于母公司股东的综合收益总额51,789,016.82223,751,739.09164,293,158.9993,129,877.9
归属于少数股东的综合收益总额759,089.864,533,387.484,133,452.673,038,824.13
公告日期2025-04-302025-03-272024-10-312024-08-29
审计意见(境内)标准无保留意见
TOP↑